Related Experiment Video
Updated: Jun 15, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Visual loss associated with tacrolimus: case report and review of the literature
Kapil G Kapoor1, Sarah N Mirza, John A Gonzales
1Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch at Galveston, 77550, USA. kgkapoor@utmb.edu <kgkapoor@utmb.edu>
Abstract:
Tacrolimus is an immunosuppressive medication in the class of calcineurin inhibitors that acts by inhibiting T-cell and interleukin-2 activity, and is commonly used after allogeneic organ transplant. We present a patient who used tacrolimus after cadaveric kidney transplant and experienced blurry vision. Ocular examination and patient's course subsequently revealed aqueous tear deficiency as a dose-dependent adverse effect of oral tacrolimus.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment